X-77681592-C-T
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4BP6_ModerateBS2
The NM_000489.6(ATRX):c.3664G>A(p.Asp1222Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000149 in 1,206,487 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 6 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_000489.6 missense
Scores
Clinical Significance
Conservation
Publications
- alpha thalassemia-X-linked intellectual disability syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
- ATR-X-related syndromeInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- intellectual disability-hypotonic facies syndrome, X-linked, 1Inheritance: XL Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -7 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ATRX | NM_000489.6 | c.3664G>A | p.Asp1222Asn | missense_variant | Exon 9 of 35 | ENST00000373344.11 | NP_000480.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000180 AC: 2AN: 111119Hom.: 0 Cov.: 23 show subpopulations
GnomAD2 exomes AF: 0.0000167 AC: 3AN: 179139 AF XY: 0.0000156 show subpopulations
GnomAD4 exome AF: 0.0000146 AC: 16AN: 1095368Hom.: 0 Cov.: 30 AF XY: 0.0000166 AC XY: 6AN XY: 361092 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000180 AC: 2AN: 111119Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33341 show subpopulations
ClinVar
Submissions by phenotype
Alpha thalassemia-X-linked intellectual disability syndrome Uncertain:1Benign:1
- -
- -
ATRX-related disorder Uncertain:1
The ATRX c.3664G>A variant is predicted to result in the amino acid substitution p.Asp1222Asn. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0037% of alleles in individuals of European (Non-Finnish) descent in gnomAD, including one hemizygous individual. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at